causal

Redundant clinical trials waste resources

When an immune therapy is approved for one cancer, rather than running one trial to test it elsewhere, thousands of redundant trials (e.g., 2200) ask the same question—each costing millions, with Phase One around $25 million and Phase Three from $500 million to $2.5 billion—so a 'me too' rush to make money stifles creativity and the development of novel targets.

causalpending

Speaker

Azra Raza

Evidence Quote

“there are 2200 trials going on to ask the same question... Phase One costs $25 million, and Phase Three costs anywhere from $500 million to $2.5 billion dollars.”

Source

Azra Raza on The First Cell— EconTalk
Created: 6/13/2026, 12:20:51 AM

Your notes

Loading notes...